US Indicts Georgian National in $1.3 Billion Medicare Billing Fraud

Federal prosecutors in Boston have charged 33-year-old Georgian citizen Erekli Gugava with money-laundering conspiracy tied to an alleged $1.3 billion healthcare billing fraud against Medicare and private U.S. insurers.

According to the U.S. Department of Justice, Gugava worked as a money launderer for an overseas criminal organization under investigation in what authorities call Operation Golden Rush. Prosecutors say the group, allegedly operating from Russia and other countries, submitted fraudulent claims for medical devices that patients never received.

The charging documents state that between February and July 2025, Gugava was the alleged owner of ND Medical, a Pennsylvania medical equipment company. During that period, ND Medical submitted at least $1.3 billion in fraudulent claims and insurers paid roughly $6.5 million. Gugava allegedly opened bank accounts in the company's name, received the funds, and then transferred them abroad to the organization.

The scheme allegedly relied on stolen personal information belonging to elderly and disabled Americans, including residents of Massachusetts and New England. Many victims discovered the fraud only when they saw insurance documents listing devices they never received, doctors they had never seen, or a company they had never heard of. Prosecutors say Gugava left the U.S. in July 2025 after the alleged activity, and that he had previously been in the country illegally. The charge carries up to 20 years in prison; the DOJ stresses that the allegations remain unproven and Gugava is presumed innocent.

How the Alleged ND Medical Scheme Exploited Medicare and Patient Data

What the ND Medical allegations show

The mechanics described by prosecutors follow a familiar healthcare fraud pattern: a shell medical equipment company submits high-volume claims for devices never delivered, using stolen patient identities. Elderly and disabled patients often have many legitimate providers, which can make bogus device claims harder to detect until an Explanation of Benefits or Medicare notice arrives.

Why Medicare and private insurers were the target

The gap between $1.3 billion in submitted claims and $6.5 million actually paid shows that insurers rejected most of the alleged billing. But even a small payout rate can still be highly lucrative for a scheme built on fabricated claims. Medicare and private insurers can be attractive targets because initial payment decisions may occur before the patient notices an unfamiliar charge.

What the DOJ action signals

The indictment is narrow so far, charging Gugava with a single money-laundering conspiracy count, but it is explicitly connected to a wider investigation named Operation Golden Rush. The penalty range, up to 20 years in prison and a fine potentially set at twice the amount laundered, underlines the seriousness of the case. Because prosecutors say Gugava has already left the country, extradition and international cooperation are likely to become central issues if the case moves forward.

What Patients and Health Plans Should Check After This Fraud Case

  • Review Medicare Summary Notices and insurer Explanation of Benefits. In this case, many victims discovered the fraud only after seeing devices or providers they did not recognize in insurance paperwork.
  • Question unfamiliar medical equipment or suppliers. If a notice lists a device you never received, a doctor you never saw, or a company you do not know, contact your insurer or Medicare immediately.
  • Report suspected fraud to 1-800-MEDICARE or the HHS Office of Inspector General. The indictment describes stolen personal data being used to bill in patients' names; early flags can stop repeat claims.
  • For health plans, audit high-value durable medical equipment claims from new suppliers. ND Medical allegedly submitted $1.3 billion in claims within five months, a pattern worth checking against delivery and prescription records.